Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHF 1535 NEXThaler versus pMDI pharmacodynamic crossover study in adult COPD
2013-002966-38Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of beclomethasone dipropionate and formoterol in chronic obstructive pulmonary disease (COPD) (5 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Average 4-hour Heart Rate. Started Sep 2013; status: completed.
02
Drugs
beclomethasone dipropionateformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2013-002966-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002966-38.